by SD-AbarceoPharma | May 15, 2026 | Events, Investors
Abarceo’s CEO Adam Bruce participated at the Almi Invest Rooftop Mingle on May 7th and gave an inspiring presentation. “I’m grateful for the opportunity to take part in this important event,” says Adam Bruce. ...
by SD-AbarceoPharma | May 23, 2025 | Diabetes, News & Press releases, VDAC1
We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
Recent Comments